The major beneficiaries of ongoing unrest in the Middle East will include companies that have lots of oil reserves, which certainly includes Brazil's Petrobras (PBR)," notes Paul Goodwin.

The editor of Cabot China & Emerging Markets Report explains, "The company is the third largest oil and natural gas company in the world, with proven oil reserves of 14.2 billion barrels. That's an 11% year-over-year gain in reserves, the largest increase in eight years.

"If you add in probable and possible reserves, the number rises to nearly 28.5 billion barrels. Proven natural gas reserves also took a big jump in 2010, rising more than 15% to 423 billion cubic meters.

"There's a little paradox in the identity of Seaspan (SSW), a company that specializes in container ships, which it acquires, crews, maintains and sails over the Seven Seas," suggests Paul Goodwin.

The global specialist suggests, "The paradox is that, despite all that ship-owning and sailing, Seaspan isn't actually a shipping company -- rather, it's a ship leasing company.

In his Cabot China & Emerging Markets Report, he continues, "Hong Kong-based Seaspan's business model is based on long-term leasing of its 57 container ships to companies that have goods to deliver.

This post is one in a series in which more than 60 newsletter advisors share their Top Stock Picks for 2011. This special report is courtesy of TheStockAdvisors.com.

"I don't have much confidence in any kind of predictions about what might happen in 2011, but I think it's a good bet that top-stock honors will go to a fresh face rather than a familiar one," says Paul Goodwin.

The editor of Cabot China & Emerging Markets Report explains, "E-Commerce China Dangdang (DANG) is an online bookseller that's been following in Amazon.com's footsteps.

"No one is more anxiously aware of the vital role of oil in running a modern industrial state than China; and when China goes looking for oil outside its own land mass, it's CNOOC Ltd. (CEO) that's carrying the checkbook," says Paul Goodwin.

The editor of Cabot China & Emerging Markets Report explains, "Short for Chinese National Offshore Oil Corporation, CNOOC was founded in 1982, and spent most of its early years exploring, drilling and pumping oil from Bohai Bay and the South China Sea.

"We're refilling our prescription with Dr. Reddy's Laboratories (RDY), the India-based generic drug maker," says Paul Goodwin.

The editor of Cabot China & Emerging Markets Report explains, "Time was, being a generic drug manufacturer in India was a pretty simple business. All you had to do was analyze a new pharmaceutical compound and figure out how to manufacture it.

"A little thing like patent protection was just a minor inconvenience. And that's how Dr. Reddy's Laboratories got started. Founder Dr. Anji Reddy used his PhD in Chemical Engineering and his experience in a state-owned pharmaceutical company to do the reverse engineering and figure out the manufacturing process.

"Focus Media Holdings (FMCN), our latest featured stock, is a leader in the advertising sector in in China; this stock is a great way to play the broad consumer market in China as that country's middle class continues to grow," says Paul Goodwin.

The editor of Cabot China & Emerging Markets Report explains, "In 2002, the company's founder, Jason Jiang, was standing in a crowd of bored office workers in Shanghai, waiting for one of the office block's infamously slow elevators to arrive.

"Then it hit him. If he could just put a little fl‚at-panel TV on the wall by the elevators, he could sell space on the screen to advertisers, translating all those increasingly affluent eyes into money.

"Modern drugs are expensive to develop; but after just 20 years, a drug can be duplicated by generic drug manufacturers and sold to those who need it for far less money," says Paul Goodwin.

The editor of Cabot China & Emerging Markets Report explains, "That's where Dr. Reddy's Laboratories (RDY) comes in. Founded in 1984 by Dr. Anji Reddy, Dr. Reddy's Labs is the main reason India has gone from a net drug importer to a net drug exporter.

"Dr. Reddy's is a growing global power in the pharmaceutical business, with a lineup of more than 50 products offered in the U.S., more than 160 products marketed in Europe, and more than 200 branded formulations available in India, Russia and other emerging markets.

"The Cabot China-Timer has flashed a new buy signal, telling us the trend of Chinese and emerging market stocks has turned back up. No one knows how long this signal will persist, and you shouldn't try to guess. Instead, your best move is to go with the evidence, which is now bullish," observes Paul Goodwin.

The editor of The Cabot China & Emerging Markets Report explains, "India's Tata Motors (TTM), the largest truck and auto maker in the subcontinent, has been a little of both over the years, but it looks like the time is right for a new advance.

Two leading international financial newsletter editors remain bullish on the prospects for China Yuchai International Limited (CYD), a maker of diesel engines.

Here's recent commentary from Nicholas Vardy, editor of The Global Bull Market Alert and Paul Goodwin, editor of The Cabot China & Emerging Markets Report.

This post is part of a special report, Top Picks for 2010, the 27th annual survey in which TheStockAdvisors.com asks the nation's leading advisors for their single favorite stock for the new year. See all 80 stocks listed here.

"My pick for the top stock of 2010 is Gafisa (GFA), a Brazilian homebuilder and developer," says emerging markets specialist Paul Goodwin.

In his The Cabot China & Emerging Markets Report, he explains, "This is an experienced growth company in a country with an excellent economic engine."

"The 'offshoring' of IT development, customer service and back office operations has always been controversial in the U.S. (because of the jobs lost)," observes Paul Goodwin.

In The Cabot China & Emerging Markets Report, he explains, "However, these outsourcing services have also been cost-effective. And outsourcing pioneer Wipro (NYSE: WIT) is very good at it.

"Wipro, the Indian megacap company, has been holding earnings steady as a rock despite the global recession that has ripped the heart out of so many companies.

"With over 950 completed projects successfully completed, Gafisa SA (NYSE: GFA) is the most successful real estate builder and developer in Brazil," says Paul Goodwin.

In The Cabot China & Emerging Markets Report, he explains, "So what is it about a Brazilian homebuilder that interests us so much? It's a combination of 'story, numbers and the chart." Here's the advisor's review.

"Brazil, one of the largest economies in the world, is still in the process of emerging from an economic crisis that began in the late 90s and bottomed out in 2002.

For those seeking exposure to the India markets, Paul Goodwin looks to HDFC Bank (NYSE: HDB), the leading private-sector bank in India.

In his The Cabot China & Emerging Markets the advisor explains, "The company puts itself at the top of its class with its relentless revenue growth, which has averaged over 42% a year." Here's his review.

"The bank became an independent company as part of the liberalization of the Indian banking industry that began in 1994.

This post is part of a 12-article feature on the best bets for investing in China. To see all the other recommendations in this special report, click here.

"The big story behind China Life Insurance (NYSE: LFC) is still the demographic one, as the population of China urbanizing and aging," says Paul Goodwin, a specialist in Asian stocks.

In his Cabot China & Emerging Markets Report, the advisor offers a fascinating look into the company, reviewing its firm's history, it's current state and assessing its future outlook.